Clinical Trial

A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD

Name: A Study on the Effect of MRD Detected by FAPI PET / CT on the Recurrence of IgG4-RD — clinical trial record (NCT07104058)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

This study intends to use the new technology of fibroblast activation protein PET / CT to study whether the tiny residual lesions detected by 68Ga-FAPI PET / CT are related to the recurrence of IgG4-RD in patients with IgG4-RD who have been clinically evaluated for complete remission after treatment.

Trial Details

NCT Number	NCT07104058
Lead Sponsor	Luo Yaping Collaborators: Peking Union Medical College Hospital
Conditions	IgG4-Related Diseases
Enrollment	46 participants
Start Date	2025-05-10
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2025-08-05